Laryngeal squamous cell carcinoma · line 1 · None
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.
| Line of therapy | 1 |
|---|---|
| Track | local_therapy |
| Linked regimen | None |
| ID | IND-LARYNGEAL-LA-1L-TOTAL-LARYNGECTOMY |
|---|---|
| Type | Indication |
| Status | reviewed 2026-07-11 | pending_clinical_signoff |
| Diseases | DIS-LARYNGEAL |
| Sources | SRC-NCCN-HNSCC-2025 |
Notes
STUB pending Clinical Co-Lead sign-off (CHARTER §6.1). Locally advanced surgical pathway — alternative to IND-LARYNGEAL-LA-1L-CRT. Concurrent postoperative chemoradiation for positive-margin/ extranodal-extension disease (Bernier EORTC 22931 / Cooper RTOG 9501 paradigm) is a DELIBERATE GAP, not modeled here — see disease- file open_gaps. Full Ukrainian rationale/do_not_do prose deferred to a follow-up localization pass.
Used By
Algorithms
ALGO-LARYNGEAL-1L- ALGO-LARYNGEAL-1L
Indication
IND-LARYNGEAL-LA-1L-CRT- IND-LARYNGEAL-LA-1L-CRT